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Adverse lung effects following pulmonary exposure to multi-walled carbon nanotubes (MWCNTs) are well
documented in rodents. However, systemic effects are less understood. Epidemiological studies have shown
increased cardiovascular disease risk after pulmonary exposure to airborne particles, which has led to concerns
that inhalation exposure to MWCNTs might pose similar risks.
We analyzed parameters related to cardiovascular disease, including plasma acute phase response (APR)
proteins and plasma lipids, in female C57BL/6 mice exposed to a single intratracheal instillation of 0, 18, 54 or
162 μg/mouse of small, entangled (CNTSmall, 0.8 ± 0.1 μm long) or large, thick MWCNTs (CNTLarge, 4 ± 0.4 μm
long). Liver tissues and plasma were harvested 1, 3 and 28 days post-exposure. In addition, global hepatic gene
expression, hepatic cholesterol content and liver histology were used to assess hepatic effects.
The two MWCNTs induced similar systemic responses despite their different physicochemical properties. APR
proteins SAA3 and haptoglobin, plasma total cholesterol and low-density/very low-density lipoprotein were
signiﬁcantly increased following exposure to either MWCNTs. Plasma SAA3 levels correlated strongly with pul-
monary Saa3 levels. Analysis of global gene expression revealed perturbation of the same biological processes
and pathways in liver, including the HMG-CoA reductase pathway. Both MWCNTs induced similar histological
hepatic changes, with a tendency towards greater response following CNTLarge exposure.
Overall, we show that pulmonary exposure to two different MWCNTs induces similar systemic and hepatic re-
sponses, including changes in plasma APR, lipid composition, hepatic gene expression and liver morphology.
The results link pulmonary exposure to MWCNTs with risk of cardiovascular disease.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Cardiovascular disease (CVD), a broad term used for all diseases of
the cardiovascular system, is the leading cause of death worldwide,
being responsible for 3 in every 10 deaths in 2008 (World Health
Organization et al., 2011). Retrospective and prospective epidemiologi-
cal studies show that pulmonary exposure to respirable air particulates
increases the risk of CVD (Chen andNadziejko, 2005; Clancy et al., 2002;
Dockery et al., 1993; Erdely et al., 2011a; Li et al., 2007; Mikkelsen et al.,
2011; Pope et al., 1995, 2004). Recent increases in the development and
use of nanomaterials will inevitably increase their presence in the envi-
ronment and thus enhance the risk of human exposure. Concern has
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been raised that this exposure may lead to increased risk of CVD (Saber
et al., 2014).
Several studies have linked pulmonary exposure to different types of
multi-walled carbon nanotubes (MWCNTs) via inhalation, instillation
or aspiration to lung inﬂammation, sustained interstitial ﬁbrosis, and
granuloma formation in rodents (Ma-Hock et al., 2009; Pauluhn,
2010a,b; Porter et al., 2010; Reddy et al., 2010; Wang et al., 2011;
Poulsen et al., 2013). In addition, extrapulmonary effects, such as
plaque progression in apoE knock-out mice, increased levels of
acute phase response (APR) proteins in the serum, and adverse devel-
opmental effects in offspring, have been reported in mice following
pulmonary exposure to CNTs (Li et al., 2007; Hougaard et al., 2013;
Erdely et al., 2011b).
Systemic effects of MWCNTsmay occur by direct translocation from
the target tissue. Indeed, several studies have reported translocation of
MWCNTs to different organs, suggesting that they are capable of cross-
ing the air–blood barrier. For example, MWCNTs were found in the
lymph nodes following instillation (Aiso et al., 2011), in the brain, kid-
ney, heart and liver following inhalation (Mercer et al., 2013;
Stapleton et al., 2012), and in the spleen, liver and bonemarrow follow-
ing pharyngeal aspiration (Czarny et al., 2014). It is also possible that
secondary effects result from MWCNT-induced release of cytokines
and APR proteins into the systemic circulation during pulmonary in-
ﬂammation. Increased concentrations of plasma APR proteins have
been reported by many epidemiological studies investigating the car-
diovascular effects of air pollution (Lowe, 2001; Mezaki et al., 2003;
Libby et al., 2010; Estabragh and Mamas, 2013; Pussinen et al., 2007).
Increased APR has been recognized as an important risk factors for
CVD (Ridker et al., 2000; Saber et al., 2013; Kaptoge et al., 2012;
Taubes, 2002; Estabragh and Mamas, 2013; Rivera et al., 2013;
Johnson et al., 2004; Pai et al., 2004; Saber et al., 2014).
The APR is characterized by changes in plasma levels of APRproteins,
including C-reactive protein (CRP), serum amyloid A (SAA) and ﬁbrino-
gen, and changes in cholesterol homeostasis following acute and chron-
ic inﬂammatory states (Bourdon et al., 2012a; Gabay and Kushner,
1999). SAA is a family of conserved and highly homologous high density
lipoprotein (HDL) apolipoproteins, which in mice are the predominant
APR proteins (Meek et al., 1992). Several tissues, including the lungs,
express the Saa3 gene. The two other isoforms, Saa1 and Saa2, are con-
sidered liver-speciﬁc but are also expressed in lungs (Bourdon et al.,
2012a; Husain et al., 2013; Uhlar and Whitehead, 1999; Halappanavar
et al., 2011; Halappanavar et al., 2014). The most studied APR protein
in humans is CRP. Physiologically, the APR is a beneﬁcial response to
local or systemic disturbances (e.g. infections); however, a persistent
chronic APR is suggested to alter blood lipids and cholesterol biosynthe-
sis, thereby increasing the risk of developing CVD (Bourdon et al.,
2012a; Lindhorst et al., 1997). In the circulation, SAA is primarily a
part of HDL. During an APR the concentration of SAA can be induced
over 1000-fold, whereby SAA replaces ApoA-1 as the major HDL pro-
tein. HDL-SAA is cleared faster from systemic circulation than regular
HDL (Hoffman and Benditt, 1983; McGillicuddy et al., 2009; Salazar
et al., 2000), and SAA remodeling of HDL impairs HDL's ability to serve
as an acceptor for macrophage cholesterol efﬂux mediated through
ABCA1. The consequences are retaining peripheral cholesterol, reduced
cholesterol biliary excretion from liver (Artl et al., 2000; Banka et al.,
1995; Lindhorst et al., 1997), and macrophage transformation into
foam cells (Artl et al., 2000; Lee et al., 2013). Foamcells are amajor com-
ponent of the fatty streak observed during development of atheroscle-
rosis, a multigenic, endothelial disease. Consistent with this, viral
vector-mediated overexpression of Saa1 in ApoE−/− mice leads to
increased plaque progression (Dong et al., 2011). Interestingly, nano-
sized titanium dioxide (nano-TiO2) from the same batch increased
both pulmonary APR in C57BL/6 mice (Halappanavar et al., 2011;
Husain et al., 2013), and induced plaque progression in ApoE−/−mice
(Mikkelsen et al., 2011) following pulmonary exposure, thus linking
nanoparticle exposure to CVD.
We recently reported that intratracheal instillation of twoMWCNTs,
a short, entangled CNTSmall and a longer, thicker CNTLarge, caused similar
increases in pulmonary inﬂammation andAPR inmice, characterized by
global mRNA changes, increased inﬁltration of inﬂammatory cells into
the lung lumen and changes in the lung morphology (Poulsen et al.,
2014). CNTSmall and CNTLarge were selected by the OECD Working
Party on Manufactured Nanomaterials and are available at the EU Joint
Research Centre. We chose these two based on their physicochemical
differences. In the present study we explore changes in various CVD
biomarkers and in hepatic gene expression in mice from the above
mentioned study at 1, 3 and 28 days following intratracheal instillation
of CNTSmall and CNTLarge.
Materials and methods
Materials. The two MWCNTs used in this study have been described
previously (Poulsen et al., 2014). Brieﬂy, the ﬁrst MWCNT (NRCWE-
026) is small and entangled, and was purchased from Nanocyl,
Belgium. In this study NRCWE-026 will be referred to as CNTSmall. The
other MWCNT (NM-401) was donated by the EU Joint Research Centre
and is longer and thicker than CNTSmall. In this study it is referred to as
CNTLarge, and it is physicochemically similar to Mitsui XNRi-7, which
was recently classiﬁed as possibly carcinogenic to humans (Group 2B)
by IARC (Grosse et al., 2014). Another batch of CNTSmall was donated
to the EU Joint Research Centre repository; so bothMWCNTs are includ-
ed in the materials of the OECD Working Party on Manufactured
Nanomaterials. The physicochemical characterization of CNTSmall and
CNTLarge, including thermal gravimetric analyses (TGA), surface area
analysis (BET), light microscopy imaging, scanning electronmicroscopy
(SEM) imaging, transmission electron microscopy (TEM) imaging and
elemental composition, has been conducted previously (Jackson et al.,
2014; Kobler et al.,2015; Poulsen et al., 2014), and the data are
summarized in the Results section.
Preparation of instillation medium and exposure stock. MWCNTs were
suspended to a concentration of 3.24 mg/ml by sonication using a
Branson Soniﬁer S-450D (Branson Ultrasonics Corp., Danbury, CT,
USA) equipped with a disruptor horn (model number: 101-147-037)
in NanoPure water containing 2% serum collected from C57BL/6 mice.
Total sonication time was 16 min at 40 W with continuous cooling on
ice. Vehicle controls contained NanoPure water with 2% serum and
were sonicated as described for the MWCNT suspensions.
Animals, exposure and tissue collection. All handling, care taking and
experimental procedures involving live animals have been reported
previously (Kobler et al., 2014, 2015). Brieﬂy, female C57BL/6 mice (6
per group) aged 5–7 weeks were allowed to acclimatize for
1–3 weeks before exposure. The mice were anesthetized with 4%
isoﬂurane until fully relaxed and with 2.5% during the instillation.
They were exposed to 18, 54 or 162 μg/animal of either CNTSmall or
CNTLarge via a single intratracheal instillation. Intratracheal instillation
was chosen since it allows for control of the deposited doses; this
would be difﬁcult with inhalation exposure. Although instillation
bypasses the upper respiratory systemand results in a rapid bolus depo-
sition, it is a valuable tool for understanding the potential systemic tox-
icity followingMWCNT exposure. Also, comparable inﬂammation levels
following MWCNT administration by pharyngeal aspiration and by in-
halation at a similar benchmark-deposited-dose have been demonstrat-
ed (Porter et al., 2013), indicating that non-inhalation administration
may predict the response following inhalation. The doses used were se-
lected for studying systemic and hepatic mechanisms following a pul-
monary exposure to MWCNTs and they are within the dose ranges of
other instillation/aspiration studies (Kim et al., 2014; Park et al., 2009;
Porter et al., 2010; Shvedova et al., 2008; Snyder-Talkington et al.,
2013). They correspond to 1, 3, and 9 days of exposure (8 h/day) to
CNTs, assuming 33% deposition rate (Ma-Hock et al., 2009; Jackson
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et al., 2011) and a ventilation rate of 1.8 l/h for mice, at the current Dan-
ish occupational exposure level for carbon black (3.5 mg/m3). When
considering the recommended exposure limit for CNTs of 1 μg/m3 per
8 hour work shift (NIOSH, 2013), the lowest dose of 18 μg/mouse corre-
sponds to the expected human work life exposure assuming a 10%
deposition (Ma-Hock et al., 2009), a ventilation rate of 1.8 l/h, a 40 h
working week and a 40 year work life. The dose of 56 μg corresponds
to 3 times the life-long dose and 162 μg/mouse corresponds to 9 times
the proposed life dose. Work place exposure to CNT are reported in the
range of 10–300 μg/m3 (Birch et al., 2011; Dahm et al., 2013; Erdely
et al., 2013; Han et al., 2008; Lee et al., 2010; Maynard et al., 2004;
Methner et al., 2010b, 2012), thus 10–300 times above the proposed ex-
posure limit. At an air concentration of 10 μg/m3, 162 μg/mouse would
correspond to the total dose during a 40-year working life, whereas
162 μg/mouse corresponds to pulmonary deposition during 1.5 work
years at 300 μg/m3. Control animals were instilled with vehicle
(NanoPure water with 2% serum). The mice were euthanized1, 3 or
28 days after exposure by exsanguination via intracardiac puncture.
Immediately after withdrawal of the heart blood (800–1000 μl), liver
tissue was collected and samples were snap-frozen in cryotubes in liq-
uid N2 and stored at−80 °C.Whole bloodwas fractionated by centrifu-
gation and plasma was collected and stored at−80 °C. Additional liver
specimenswere taken from 12 to 24 vehicle control mice and from 5 to
6 mice from groups treated with either CNTSmall or CNTLarge. Tissues
were ﬁxed in 4% neutral buffered formaldehyde, parafﬁn-embedded
and sections 4–6 μm thick were stained with hematoxylin and eosin
(HE) for histological examination.
All animal procedures followed the guidelines for the care and
handling of laboratory animals established by Danish law. The Animal
Experiment Inspectorate under the Ministry of Justice approved the
study (#2010/561-1779).
Plasma protein measurements. ELISA analysis speciﬁcally targeting
plasma SAA3 levels was conducted in accordance with the manufac-
turer's instructions (Mouse Serum Amyloid A-3, Cat.#EZMSAA3-12K,
Millipore). All of the time points and doses were evaluated. Samples
were pooled to a ﬁnal N of 3 per group (representing 6 mouse samples
in total). Plasma haptoglobin was determined by ELISA (mouse hapto-
globin (Hpt/HP) ELISA kit, Cat. #CSB-E08586m, Cusabio) as described
by the manufacturer. The high dose only from all time points was
evaluated. The samples were pooled to a ﬁnal N of 3 per group.
The statistical analyseswere performed in SAS version 9.3 (SAS Insti-
tute Inc., Cary, NC, USA). Statistical signiﬁcance was calculated using a
parametric two-way ANOVA with a post-hoc Tukey-type experimental
comparison test. In case of interaction between dose and time, the data
were separated in time points and a one-way ANOVA with a post-hoc
Tukey-type experimental comparison test was performed. For the sta-
tistical analysis of haptoglobin protein levels, no statistically signiﬁcant
time-variance between controls was found; thus, controls from all time
points were pooled.
Plasma lipid composition. Plasma levels of total cholesterol, HDL and
low-density lipoprotein/very low-density lipoprotein (LDL/VLDL) in
mice exposed to CNTSmall and CNTLarge were determined colorimetrical-
ly with the EnzyChrom™ AF HDL and LDL/VLDL assay kit (EHDL-100,
BioAssay Systems) according to the manufacturer's instructions. All
time points and doses were evaluated with 6 animals per treatment
group. Brieﬂy, a standard sample was produced from a standard choles-
terol reference supplied by themanufacturer. HDLwas isolated from the
supernatant following centrifugation of a 1:1 plasma-precipitating re-
agent solution. The LDL/VLDL fraction was separated by dissolution of
the collected pellet from the 1:1 plasma-precipitating reagent solution
in PBS. Plasma cholesterol, HDL, and LDL/VLDL isolations from each
sample and a standard cholesterol reference supplied by the manufac-
turer were placed in 50 μl aliquots as duplicates in a 96-well plate.
Sixty microliters of a NAD-enzyme buffer mix was added, and the
platewas incubated at room temperature for 30min. Fluorescencemea-
surements were recorded on Victor2 1420 Multi label counter (Wallac,
Perkin-Elmer) at OD 340 nm and cholesterol concentrations were de-
termined by comparison to the standard sample.
Plasma triglyceride levels were determined using the EnzyChrom™
AF Triglyceride assay kit (BioAssay Systems, ETGA-200) according to the
manufacturer's instructions. All time points and doses were evaluated.
Therewere 6 animals per treatment group. Brieﬂy, a 10-fold serial dilut-
ed standard curve was produced from a standard cholesterol reference
supplied by the manufacturer. Ten microliter aliquots of standard and
sample were placed in duplicate in a 96-well plate, and 100 μl of a dye
reagent-enzyme mix was added. The plate was incubated at room
temperature for 30 min. The color intensity of the reaction product
was determined spectrophotometrically at OD 570 nm on a Victor2
1420 Multi label counter (Wallac, Perkin-Elmer), and total triglyceride
concentrations were determined by a standard curve.
All statistical analyses on lipid levels were performed in SAS version
9.2 (SAS Institute Inc., Cary, NC, USA). Statistical signiﬁcance was calcu-
lated using a parametric one-way ANOVA with a post-hoc Tukey-type
experimental comparison test.
Total lipid extraction and total hepatic cholesterol analysis. Total lipids
were extracted from liver tissue according to the Folch method (Folch
et al., 1957). In brief, approximately 4–5mg of liver tissuewas collected
from the sample and theweightwas noted. The liver tissuewas homog-
enized in 250 μl methanol and 250 μl water. A double volume of 5:1
chloroform/methanol was then added, and phases were separated by
centrifugation. The lower layer containing chloroform/lipid was collect-
ed, and the chloroform removed under nitrogen gas ﬂow. Lipids were
resuspended in 100 μl EnzyChrom assay buffer and stored at−20 °C
until analysis.
Colorimetric quantiﬁcation of hepatic cholesterol levels was deter-
mined with the EnzyChrom™ AF Cholesterol assay kit (BioAssay Sys-
tems, E2CH-100) according to the manufacturer's instructions. All time
points and doses were evaluated with 6 animals per treatment group.
Brieﬂy, a 10-fold serial diluted standard curvewas produced from a stan-
dard cholesterol reference supplied by themanufacturer. Fifty microliter
aliquots of standard and sample were placed in duplicate in a 96-well
plate, and 50 μl of a dye reagent–enzyme mix was added. The plate
was incubated at room temperature for 30 min. The color intensity of
the reaction product was spectrophotometrically measured at OD
570 nm on a Victor2 1420 Multi label counter (Wallac, Perkin-Elmer),
and total cholesterol concentrations were determined by comparison
to the standard curve, with normalization to extracted tissue weight.
Total RNA extraction. Total RNA was isolated from liver tissue of 144
mice in total (N was 6 mice per dose group and time point). The RNA
was isolated using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) and
puriﬁed using RNeasy MiniKits (Qiagen, Mississauga, ON, Canada) as
described by the manufacturer. On-column DNase treatment was ap-
plied (Qiagen, Mississauga, ON, Canada). All RNA samples showing
A260/280 ratios between 2.0 and 2.15 were further analyzed for RNA in-
tegrity using an Agilent 2100 Bioanalyzer (Agilent Technologies, Missis-
sauga, ON, Canada). RNA integrity numbers above 7.0 were used in the
experiment. If the RNA samples did not fulﬁll the criteria, new RNA ex-
tractions from the liver tissue were performed. Total RNA was stored at
−80 °C until analysis.
Microarray hybridization. We have found changed hepatic gene expres-
sion only after pulmonary exposure to high doses of nano-TiO2 or nano-
carbon black (nano-CB) (Bourdon et al., 2012a; Husain et al., 2013).
Therefore, microarray analysis was done only for the 0 and 162 μg
dose groups in this study. The two lower doses (18 and 54 μg) were
included for time points 1 and 3 days in the subsequent RT-PCR
conﬁrmation of the microarray results. A total of 200 ng of RNA from
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each sample (6 per treatment group) was analyzed by microarray hy-
bridization on Agilent 8 × 60 K oligonucleotide microarrays (Agilent
Technologies Inc., Mississauga, ON, Canada) as described previously
(Poulsen et al., 2013). Data were acquired using Agilent Feature Extrac-
tion software version 9.5.3.1.
Statistical, functional and pathway analysis of microarray data. The
microarray data were analyzed as described previously (Poulsen et al.,
2013, 2014). Genes showing expression changes of at least 1.5-fold in
either direction compared to their matched controls and having false
discovery rate adjusted p-values of less than or equal to 0.05 (FDR
p ≤ 0.05) were considered signiﬁcantly differentially expressed and
were used in the downstream analysis. We used the Database for
Annotation, Visualization and Integrated Discovery (DAVID) v6.7 and
Ingenuity Pathway Analysis (IPA, Ingenuity Systems, Redwood City,
CA, USA) for functional and pathway analyses, as previously described
(Poulsen et al., 2014). The gene ontology (GO) classiﬁcation of the
differentially expressed genes was explored; GO consists of three struc-
tured controlled vocabularies (ontologies) that describe gene products
in terms of their associated biological processes, cellular components
and molecular functions in a species-independent manner. In the
present study GO biological processes were utilized.
qRT-PCR validation. Eighteen genes were selected for further validation
by qRT-PCR in liver tissue using custom RT2 Proﬁler PCR Arrays and a
BioRad CFX96 real-time PCR detection system at doses 0, 18, 54 and
162 μg for post-exposure days 1 and 3, and at doses 0 and 162 μg at
post-exposure day 28. The selected differentially expressed genes
(FDR p ≤ 0.05, FC 1.5 in at least one condition) showed large changes
in expression following MWCNT exposure, and/or were associated
with lipid homeostasis, or inﬂammatory and acute phase responses.
A custom RT2 Proﬁler PCR Array plate, the RT2 First Strand Kit and
RT2 SYBR® Green qPCR Mastermix (QIAGEN Sciences, Maryland,
USA) was used. Hypoxanthine-guanine phosphoribosyltransferase
(Hprt), actin β (Actb) and glyceraldehyde 3-phosphate dehydrogenase
(Gapdh) were used as reference genes for normalization and were se-
lected based on their stable expression levels in the treated and control
samples in the microarray analysis. A threshold value was set to 102.
The ﬁnal qRT-PCR validation group consisted of a sample size of 3 per
treatment condition.
Results
MWCNT
Detailed physicochemical characterization of thematerials has been
published elsewhere (Kobler et al., 2014; Jackson et al., 2014; Kobler
et al., 2015; Poulsen et al., 2014). In brief, CNTSmall were 847 ±
102 nm long and 11 (6–17) nm wide. They contained 87% carbon and
had a BET surface area of 245.8 m2/g. A chemical analysis of CNTSmall
from the same batch showed that main components of CNTSmall
(NRCWE-026) included the following: C (84.4%), Al2O3 (14.97%),
Fe2O3 (0.29%) and CoO (0.11%) (Jackson et al., 2014). CNTSmall appeared
curly and highly entangled when visualized by TEM and SEM. CNTLarge
were 4048 ± 366 nm in length and had an average width of 67
(24–138) nm. CNTLarge consisted of 97% carbon and the BET surface
area was 14.6 m2/g. The chemical composition of CNTLarge from the
samebatch showed that themain components of CNTLarge (NM-401) in-
cluded the following: C (99.7%), P2O5 (0.14%), CO3 (0.08%) and Fe2O3
(0.05%) (Jackson et al., 2014). CNTLarge appeared large and straight
when visualized by TEM and SEM.
Plasma protein analysis
Plasma levels of SAA3 were statistically signiﬁcantly increased in
mice exposed to both types of MWCNTs. This was observed following
CNTSmall exposure in the high dose group on post-exposure day 1 and
day 28, and at all doses on post-exposure day 3 (4.3-, 7.0-, 2.5-, 10.4-,
and 32.8-fold increase, respectively) (Fig. 1A). CNTLarge exposure result-
ed in increased SAA3 levels following high dose exposure on day 1, and
at the medium and high dose on post-exposure day 3 (6.9, 3.2 and 61.0
fold increase, respectively) (Fig. 1A). There were no changes at 28 days
after CNTLarge exposure. One observation in the control group on day 28
was an outlier (more than 2 SD difference from the other values),
resulting in a relatively high control SAA3 plasma protein content.
If this observation was excluded, the difference was statistically signiﬁ-
cant for both medium and high dose exposures 28 days post-exposure.
Interestingly, we observed large increases in pulmonary Saa3 mRNA
levels in the same animals after pulmonary exposure to CNTSmall and
CNTLarge (Poulsen et al., 2014). Pulmonary Saa3mRNA levels correlated
strongly with SAA3 protein levels in the plasma (Fig. 1B) (linear regres-
sion; p b 0.0005 across time points andMWCNT dose). The haptoglobin
plasma levelswere statistically signiﬁcantly increased 3 days after expo-
sure to 162 μg CNTSmall and CNTLarge compared to vehicle controls
(Fig. 1C), but were not changed at other time points.
Alterations in cholesterol homeostasis
Compared to the controls, total cholesterol levels were greatly in-
creased after exposure to either type of MWCNT on day 3 at the high
dose (58% and 51% for CNTSmall and CNTLarge, respectively) (Fig. 2A)
and on post-exposure day 1 for CNTLarge (28%). Signiﬁcantly higher
LDL/VLDL plasma levels were found for the high dose 3 days post-
exposure groups for both MWCNTs (153% and 128% for CNTSmall and
CNTLarge respectively) (Fig. 2B). HDL levels were increased following
high dose exposure to CNTSmall on day 3 (42%). A similar but statistically
non-signiﬁcant increase was observed for CNTLarge under the same ex-
posure conditions (31%) (Fig. 2C). The ratios between plasma HDL and
LDL/VLDL levels in the controls (CNTSmall: 3.56, CNTLarge: 3.22) com-
pared to the high dose exposed mice at day 3 (CNTSmall: 1.92, CNTLarge:
1.94) showed that the increase in the LDL/VLDL level was greater than
the increase in HDL following exposure. Plasma triglyceride levels
were unaffected by CNTSmall and CNTLarge exposure (results not shown).
No change in total hepatic cholesterol levels was observed for
CNTSmall, but a statistically signiﬁcant 47% increase was observed for
CNTLarge on post-exposure day 3 (Fig. 2D).
Microarray analysis
The experiments and analyses adhered to MIAME standards (Edgar
and Barrett, 2006). All microarray data have been deposited in the
NCBI Gene Expression Omnibus database and can be accessed through
the accession number GSE61366.
Alterations in global hepatic gene expression.
Global hepatic gene expression was assessed for the highest dose of
both MWCNT exposures for all three time points. For CNTSmall exposed
mice, a total of 4028 of the 60,000 probes were differentially expressed
in hepatic tissue. On day 1, day 3 and day 28 the expression of 2505,
2401, and 255 genes, respectively, was changed (Supplementary
Table 1). Fig. 3A shows the overlap of differentially expressed genes
across time points. CNTLarge had a slightly smaller effect on hepatic
gene expression than CNTSmall exposed mice, but still caused a signiﬁ-
cant effect; a total of 3089 probes were differentially expressed com-
pared to controls. On day 1, the expression of 2128 genes was
changed, and on day 3, 1667 gene expressions were altered. No genes
were signiﬁcantly differentially expressed on day 28. As observed after
exposure to CNTSmall, many of the same genes were differentially
expressed on day 1 and day 3 (Fig. 3B).
GO classiﬁcation analysis in DAVID (Huang et al., 2009a,b) revealed
statistically signiﬁcant perturbations in biological processes in the liver
at the early time points (day 1 and 3) only. The common GO biological
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processes affected following CNTSmall and CNTLarge exposure are shown
in Fig. 3C. We observed a high degree of concordance between the two
MWCNTs for enriched GO biological processes, especially for oxidation
reduction [GO:0055114], steroid metabolic process [GO:0008202],
lipid biosynthetic process [GO:0008610], fatty acid metabolic process
[GO:0006631], cofactor metabolic process [GO:0051186] and immune
response [GO:0006955], which were differentially enriched both 1
and 3 days following CNTSmall and CNTLarge exposure. The uniquely dif-
ferentially regulated biological processes are shown in Supplementary
Table 2 and revealed few major differences. Several of the highly
enriched processes in common for the two MWCNTs were associated
with lipid homeostasis. Remarkably similar and pronounced effects on
gene expression for bothMWCNTswere observed by functional annota-
tion clustering (Supplementary Table 3), where lipid metabolic process
was the top scoring cluster at the early timepoints. Across bothMWCNT
types at the early points, oxidation reduction [GO:0055114] was the
most enriched regulated biological process. Several of the differentially
regulated genes under this process were involved in other biological
processes as well, including lipid homeostasis processes.
IPA was employed to relate the functional signiﬁcance of the GO
changes to biological functions and pathways. The individual enriched
functions in IPA were ﬁltered by 1) removing redundant functions
with overlapping genes, and 2) removing functions that were not
directly relevant to the present study (e.g. renal diseases, ophthalmic
diseases etc.). By using these criteria, we identiﬁed the top 5most signif-
icantly affected functions after CNTLarge exposure, and we compared
these to the corresponding functions following CNTSmall exposure
(Supplementary Fig. 1). The top-regulated functions were similar for
both MWCNTs, with 3 out of 5 of the most regulated functions being
the same. ‘Lipid metabolism’was the most enriched function, in agree-
ment with the observed changes in the GO biological processes involv-
ing lipid homeostasis. The third most perturbed function after CNTSmall
exposure was ‘cardiovascular disease’, and the ﬁfth was ‘carbohydrate
metabolism’.
Inﬂammation and acute phase response signaling.
Inﬂammatory processes were among the most perturbed processes
in the liver. These were in part driven by changes in the mRNA levels
of several cytokines, including the following: Cxcl1, Cxcl9, Cxcl10,
Cxcl13, Ccl6, Ccl27a and Ccl25. We also found differential expression
of APR genes in the liver following MWCNT exposure including the
following: Saa1, Saa2, Saa3, Saa4, Orm1, Orm2, Orm3, Mt1 and Mt2
(Supplementary Table 4). As recently reported, strong pulmonary in-
ﬂammatory and APR, both as increased neutrophil inﬂux and increased
expression of cytokines and APR genes, were found in these mice
following same exposure to CNTSmall and CNTLarge (Poulsen et al., 2014).
Regulation of cholesterol homeostasis.
Analysis of the global hepatic gene expression revealed consistent
perturbation of lipid homeostasis related functions and pathways.
Genes involved in the HMG-CoA reductase pathway were substantially
down-regulated in the liver for bothMWCNTs, which is consistent with
perturbations in lipid processes identiﬁed using DAVID (Fig. 3C) and
functional analysis in IPA (Supplementary Fig. 1 and Supplementary
Table 3). CNTSmall was themost effective in perturbing theHMG-CoA re-
ductase pathway (Hmgcr,Mvk, Pmvk,Mvd, Fdps, Sqs, Sqle, Dhcr7) in the
liver. The changes in gene expression were similar on days 1 and 3
(Table 1). In addition to the HMG-CoA reductase pathway, other genes
Fig. 1. Plasma protein levels of SAA3 and haptoglobin following exposure to CNTSmall or CNTLarge. (A) Plasma levels of SAA3 protein following intratracheal instillation of 0, 18, 54 or 162 μg
CNTSmall or CNTLarge at post-exposure day 1, 3 or 28. (B) Linear regression analysis of pulmonary Saa3mRNA fold changes after microarray analysis and plasma SAA3 protein fold changes
following ELISA analysis. Both microarray and protein level data have been log transformed. (C) Plasma levels of haptoglobin protein following intratracheal instillation of 0 or 162 μg
CNTSmall or CNTLarge at post-exposure day 1, 3 or 28. *Statistically signiﬁcantly different from vehicle instilled mice, p b 0.05. **Statistically signiﬁcantly different from vehicle instilled
mice, p b 0.01. ***Statistically signiﬁcantly different from vehicle instilled mice, p b 0.001. Error bars denote SD.
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involved in lipid homeostasis were also affected by MWCNT exposure.
Low density lipoprotein receptor (Ldlr) was down-regulated after
CNTSmall exposure on day 1 (−1.79-fold) and day 3 (−1.7-fold), and
after CNTLarge exposure at day 3 (−1.56-fold) (Table 1). Gene expres-
sion of another membrane protein, scavenger receptor class B, member
1 (Scarb1), was also down-regulated for CNTSmall day 1 (−1.53-fold),
whereas expression of low density lipoprotein receptor-related protein
1 (Lrp1) was up-regulated on day 3 for both MWCNTs (CNTSmall 1.84-
fold, CNTLarge 2.09-fold). Scarb1 and Lrp1 are involved in the transport
of HDL and LDL, respectively, over the hepatocyte cell membrane. A
small up-regulation in the expression of Abca1 was identiﬁed 3 days
post-exposure for CNTSmall (1.68-fold).
Besides the HMG-CoA reductase pathway, analysis of canonical
pathways in IPA (Supplementary Fig. 2) also revealed enrichment of
LXL/RXR activation, glutathione-mediated detoxiﬁcation, acute phase
response signaling, nicotine degradation III, hepatic cholestasis and
xenobiotic metabolism signaling pathways. Analysis of the LXL/RXR
activation pathway on day 3 for both MWCNTs revealed that most up-
stream and downstream genes related to the LXL/RXR heterodimer
complex show changes in expression (Supplementary Fig. 3), including
cholesterol transporter Abca1. As observed for the HMG-CoA pathway,
CNTSmall exposure induced the largest change in gene expression of
genes in this pathway.
qRT-PCR validation
We validated 18 differentially expressed genes in liver tissue follow-
ing pulmonary exposure to 162 μg CNTSmall or CNTLarge at post-exposure
day 1, 3 or 28. These genes were chosen due to their involvement in
lipid homeostasis (Hmgcr, Pmvk, Mvd, Fdps, Dhcr7, Ldlr, Lrp1, Cyp7a1,
Abca1), inﬂammatory and APR (Cxcl1, S100a9, Saa1, Saa2, Saa3, Il1r1)
or due to large changes in their expression following MWCNT exposure
(Sult1e1, Scd1, Dbp). In addition to this validation, we evaluated the 18
and 54 μg exposure groups on post-exposure days 1 and 3 in order to
assess hepatic changes following lower dose MWCNT exposure. The
qRT-PCR results are provided in Table 2 and are consistent with the
DNA microarray results. The lipid homeostasis genes Hmgcr, Ldlr and
Cyp7a1 were differentially expressed at all doses on days 3 and 28
after CNTSmall exposure, but not following CNTLarge exposure. In con-
trast, there was a tendency towards greater enrichment of inﬂammato-
ry and APR genes following exposure to CNTLarge compared to CNTSmall.
The expression of Dbp, a PAR leucine zipper transcription factor
involved in circadian rhythm regulation, was consistently down-
regulated at all doses and time points following exposure to CNTSmall,
whereas CNTLarge exposure resulted in up-regulation of the expression
at the high and medium dose on post-exposure day 1.
Liver histology
Different doses of CNTSmall or CNTLarge induced histological changes
in the liver at different times (Fig. 4 and Supplementary Table 5) with
no apparent dose- or time-dependence. No translocation of MWCNTs
from lungs to liver was observed. Changes such as vacuolar degenera-
tion (Figs. 4C–J), granulomas (Figs. 4C and G–J), necrosis of hepatocytes
(Figs. 4D and I–J), increased number and/or hypertrophy of Kupffer cells
(Figs. 4A and I–J) were frequent in CNT-treated mice. For both MWCNT
types the incidence of lesions was higher 3 and 28 days after exposure
than on post-exposure day 1. The sites of vacuolar degeneration in the
cytoplasm of hepatocytes within the hepatic lobule differed between
CNTSmall and CNTLarge exposure. Whereas the vacuolar degeneration
Fig. 2. Changes in plasma and hepatic cholesterol levels following exposure to CNTSmall or CNTLarge. (A) Plasma total cholesterol, (B) plasma LDL, (C) plasma HDL and (D) hepatic total cho-
lesterol in C57BL/6 mice exposed to 0, 18, 54 or 162 μg CNTSmall or CNTLarge at post-exposure day 1, 3 or 28. *Statistically signiﬁcantly different from vehicle instilled mice, p b 0.05. **Sta-
tistically signiﬁcantly different from vehicle instilled mice, p b 0.01. ***Statistically signiﬁcantly different from vehicle instilled mice, p b 0.001. Error bars denote SD.
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after CNTLarge exposure was distributed throughout the whole area of
the hepatic lobule regardless of the time after instillation, after CNTSmall
exposure it was located in the centrilobular zone (i.e. near the central
vein) 1 day after exposure, mid-zonal three days after exposure and in
the periportal zone 28 days after exposure. Although liver granulomas
were observed after exposure to both MWCNTs, they were larger and
more frequent following CNTLarge exposure (Figs. 4C and G–J). Microfoci
of necrosis, eosinophilic necrosis and hepatocytes with pyknotic nuclei
were seen following exposure to either MWCNT and were located
close to granulomas; however, they were more frequent after CNTLarge
exposure. Eosinophilic necrotic hepatocytes surrounding the central
vein were observed in the livers of mice 1 or 3 days after exposure to
162 μg CNTLarge. Increased number and hypertrophy of Kupffer cells
were observed more frequently in livers frommice exposed to CNTLarge
(Figs. 4D and I–J). Binucleate hepatocytes were more frequent in the
livers of exposed mice than in the controls. Overall, pulmonary expo-
sure to CNTLarge was associated with increased incidence and severity
of morphological liver lesions compared to exposure to CNTSmall.
Fig. 3. Hepatic transcriptomic changes. (A) Venn diagram of differentially expressed genes following exposure to 162 μg CNTSmall. p b 0.05 and fold change ±1.5. (B) Venn diagram of
differentially expressed genes following exposure to 162 μg CNTLarge. p b 0.05 and fold change ±1.5. (C) Changes in GO biological processes in the liver following exposure to CNTSmall
and CNTLarge. Determined through DAVID Bioinformatics Resources 6.7.
Table 1
Differentially expressed hepatic genes involved in lipid metabolism processes following exposure to CNTSmall or CNTLarge.
Gene name CNTSmall CNTLarge
Day 1 Day 3 Day 28 Day 1 Day 3 Day 28
FC p-Value FC p-Value FC p-Value FC p-Value FC p-Value FC p-Value
HMG-CoA reductase (HMGCR) −2.18 0.013 −3.0 0.001 – – – – −2.63 0.005 – –
Mevalonate kinase (MVK) −1.98 0.006 – – – – – – – – – –
Phosphomevalonate kinase (PMVK) −3.05 0.0 −1.75 0.001 – – −2.27 0.0 −2.66 0.0 – –
Mevalonate-5-pyrophosphate (MVD) – – −2.22 0.012 – – – – −2.93 0.001 – –
Farnesyl-PP synthase (FDPS) −2.31 0.000 −1.89 0.017 – – −2.67 0.0 −3.16 0.0 – –
Squalene synthase (SQS) −1.75 0.009 – – – – – – – – – –
Squalene epoxydase (SQLE) −2.05 0.025 – – – – – – – – – –
7-Dehydrocholesterol reductase (DHCR7) −2.22 0.0 −1.99 0.0 – – −2.09 0.0 −2.33 0.0 – –
Low density lipoprotein receptor (LDLR) −1.79 0.002 −1.70 0.006 – – – – −1.56 0.041 – –
Low density lipoprotein receptor-related protein 1 (LRP1) – – 1.84 0.0 – – – – 2.09 0.0 – –
Scavenger receptor class B, member 1 (SCARB1) −1.53 0.0 – – – – – – – – – –
Cytochrome P450, family 7, subfamily a, polypeptide 1 (CYP7A1) – – −20.16 0.0 – – – – −4.0 0.007 – –
Hepatic lipase (LIPC) – – −1.50 0.002 – – – – – – – –
ATP-binding cassette, sub-family A, member 1 (ABCA1) – – 1.68 0.0 – – – – – – – –
FC: Fold change. –: Not signiﬁcantly differentially expressed. Numbers are statistically signiﬁcant at least at the p b 0.05 level.
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Discussion
In this study we investigated extrapulmonary effects in female
C57BL/6mice 1, 3 or 28 days following a single, intratracheal instillation
of either of two MWCNTs with very different physicochemical proper-
ties. We report increased plasma levels of the APR protein haptoglobin
and a large, sustained increase in plasma SAA3 protein levels following
exposure to both types of MWCNTs. Systemic increases in haptoglobin
and SAA levels have been observed previously following pulmonary
CNT exposure (Erdely et al., 2011b; Saber et al., 2013), with increased
SAA3 levels being detected up to one year post-exposure in male mice
(Kim et al., 2014). We recently reported that CNTSmall and CNTLarge ex-
posures, despite physicochemical ﬁber dissimilarities, elicit very similar,
strong pulmonary inﬂammation and APR (Poulsen et al., 2014). This
pulmonary APR was characterized by time- and dose-dependent
increases in the expression of a number of acute phase genes, with
Saa3 being the most differentially expressed gene. We have previously
reported similar ﬁndings for other nanomaterials and particles (Saber
et al., 2014). In the present study, we observed a strong and statistically
signiﬁcant linear relationship between the pulmonary Saa3 mRNA
levels and SAA3 plasma levels (Fig. 1B), indicating a probable pulmo-
nary origin of plasma SAA3. The hepatic expression levels of Saa3
following CNTSmall and CNTLarge exposure were 10 to 100 times lower
than the expression levels of pulmonary Saa3, thus indicating that the
observed systemic APR may be a secondary response to the pulmonary
APR induced by MWCNTs. This is in agreement with previous reports
showing that pulmonary exposure to CB, diesel exhaust particle and
MWCNTs induced little or no hepatic APR, but a large pulmonary APR
(up to a 600-fold increase) (Bourdon et al., 2012a,b; Saber et al., 2009,
2013, 2014).
Elevated plasma levels of APR proteins are a recognized risk factor
for CVD (Estabragh and Mamas, 2013; Johnson et al., 2004; Kaptoge
et al., 2012; Libby et al., 2010; Lowe, 2001; Mezaki et al., 2003; Pai
et al., 2004; Pussinen et al., 2007; Ridker et al., 2000; Rivera et al.,
2013; Saber et al., 2013; Taubes, 2002). Epidemiological studies have
established associations between particulate air pollution exposures
and blood levels of CRP (Elliott et al., 2009; Barregard et al., 2006;
Allen et al., 2011; Hertel et al., 2010; Ohlson et al., 2010). Increased
blood levels of SAA and CRP were associated with future risk of CVD in
the Nurses' Health Study (Ridker et al., 2000). The Nurses' Study report-
ed that a 5-fold increase in blood SAA levelswas associatedwith a 3-fold
increased risk of coronary heart disease. Comparable increases in SAA3
levels were reported in the present study (7-fold increase, 28 days fol-
lowing pulmonary CNTSmall exposure) and in male mice by (Kim et al.,
2014) (4-fold increase, one year following pulmonary MWCNT expo-
sure), indicating that human exposure to doses comparable to those in
Table 2
Hepatic mRNA expression changes for selected genes in mice 1, 3 and 28 days post-exposure to 18 μg, 54 μg and 162 μg CNT.
CNTSmall Day 1 Day 3 Day 28
PCR array Microarray PCR array Microarray PCR array Microarray
Genes 18 μg 54 μg 162 μg 162 μg 18 μg 54 μg 162 μg 162 μg 162 μg 162 μg
Sult1e1 – – 51.3 42.2 – – 58.6 27.3 – –
Scd1 –2.5 −2.3 −2.5 – – – −227.5 −47.1 – –
Cxcl1 – – – – – – 63.3 18.6 – –
S100a9 – – – 2.4 – – 17.1 12.2 – –
Saa1 – – – 2.6 1.8 4.7 – 8.2 – –
Saa2 – – – – – – – 6.1 – –
Saa3 – – – – – – – 2.2 – –
Il1r1 – – 3.5 5.2 −1.8 – 18.1 10.1 – –
Hmgcr −2.4 – – −2.2 −3.4 −3.4 −4.5 −3.0 −3.4 –
Pmvk – – −2.9 −3.1 – – – −1.8 – –
Mvd – – – – – – −3.0 −2.2 −2.6 –
Fdps – – −2.5 −2.3 – – – −1.9 – –
Dhcr7 – – −2.0 −2.2 – – – −2.0 – –
Ldlr −2.1 – −1.5 −1.8 −2.4 −2.2 −2.5 −1.7 −2.0 –
Lrp1 – – – – – – 1.9 1.8 – –
Cyp7a1 −23.3 – – – −6.6 −3.8 −39.3 −20.2 −2.1 –
Abca1 – 1.5 – – – – – 1.7 – –
Dbp −26.1 −4.6 −4.0 −7.9 −33.8 −11.0 −7.7 −10.1 −22.7 −12.3
CNTLarge Day 1 Day 3 Day 28
PCR array Microarray PCR array Microarray PCR array Microarray
Genes 18 μg 54 μg 162 μg 162 μg 18 μg 54 μg 162 μg 162 μg 162 μg 162 μg
Sult1e1 – – 172.6 34.7 – – 28.3 11.5 – –
Scd1 – – −1.9 −1.8 – – −111.9 −52.4 – –
Cxcl1 – – – 3.6 – – 72.2 14.1 – –
S100a9 – – 4.4 2.4 – – 7.7 4.1 – –
Saa1 – 10.4 – 3.0 – – 3839.4 9.1 – –
Saa2 – 10.6 – 2.8 2.4 – 2521.4 8.2 – –
Saa3 – – – – – – 9.5 3.2 – –
Il1r1 1.6 – 8.7 5.9 – – 10.9 4.4 – –
Hmgcr – – – – – – – −2.6 – –
Pmvk – – – −2.3 – – −2.0 −2.7 – –
Mvd – – – – – – −2.5 −2.9 – –
Fdps – – – −2.7 – – −2.3 −3.2 – –
Dhcr7 – – – −2.1 – – −2.2 −2.3 – –
Ldlr – – – – – – – −1.6 – –
Lrp1 – – – – – – 2.7 2.1 – –
Cyp7a1 – – – – – – – −4.0 – –
Abca1 – – – – – – 2.2 – – –
Dbp – 11.7 5.4 – – – – – – –
Fold change compared to vehicle instilled control mice. –: Not signiﬁcantly differentially expressed. Numbers are statistically signiﬁcant at least at the p b 0.05 level.
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these two murine studies may increase the risk of CVD in humans.
Occupational studies have reported human CNT exposure levels of
10–300 μg/m3 (Birch et al., 2011; Dahm et al., 2013; Erdely et al.,
2013; Han et al., 2008; Lee et al., 2010; Maynard et al., 2004; Methner
et al., 2010a, 2012). The highest dose in the present study corresponds
to pulmonary deposition during a 40 year working life at 10 μg/m3, or
to pulmonary deposition during 1.5 work years at 300 μg/m3. Further-
more, based on the observed strong correlation between plasma SAA3
levels and pulmonary Saa3 mRNA levels, and the reported correlation
between pulmonary neutrophil inﬂux and pulmonary Saa3 mRNA
levels (Saber et al., 2013), pulmonary Saa3 expression or neutrophil
inﬂux may be used as sensitive biomarkers of nanomaterial-induced
acute phase response andmay be used to group and rank nanomaterials
in relation to possible CVD inducing potential.
The APR, and SAA in particular, affect blood lipid homeostasis and
regulation of cholesterol biosynthesis (Bourdon et al., 2012a;
Lindhorst et al., 1997; Saber et al., 2013, 2014). We show that pulmo-
nary exposure to two very different MWCNTs induces changes in
blood lipid composition that are similar to changes observed after sys-
temically induced APR (Lindhorst et al., 1997). The data indicate that
both MWCNTs cause perturbations in lipid-related processes as early
as 1 day post-exposure, reaching their peak increases on day 3 and
Fig. 4.Histopathologic ﬁndings in the liver. (A) 1 day after instillation (a.i.) of 54 μg CNTSmall: Hypertrophy of Kupffer cells (long arrows), numerous binucleate hepatocytes (short arrows).
(B) 1 day a.i. of 162 μg CNTSmall: Macrophage (long arrow), central zonal vacuolar (hydropic) degeneration (short arrows). (C) 3 days a.i of 54 μg CNTSmall: Granuloma surrounded by
eosinophilic necrotic hepatocytes (long arrow), vacuolar degeneration (short arrows); (D) 28days a.i. of 162 μg CNTSmall: Foci of necrosis (asterisks), vacuolar degeneration (short arrows),
hyperplasia of the bile ducts epithelium (long arrow). (E) 1 day a.i. of 162 μg CNTLarge: Eosinophilic necrotic hepatocytes surrounding central vein (long arrows), vacuolar degeneration of
hepatocytes on the whole area of the liver lobule (head of arrows), and numerous binucleate hepatocytes (short arrows). (F) 3 days a.i. of 18 μg CNTLarge: Focus of eosinophilic necrotic
hepatocytes (long arrow), vacuolar degeneration of hepatocytes on the whole area of the liver lobule (short arrows). (G) 3 days a.i. of 54 μg CNTLarge: Granuloma surrounded by eosino-
philic necrotic hepatocytes (arrows), vacuolar degeneration (short arrows). (H) 3 days a.i. of 162 μg CNTLarge: Granuloma surrounded by eosinophilic necrotic hepatocytes (long arrow),
vacuolar degeneration (short arrows), numerous binucleate hepatocytes (head of arrows). (I) 28 days a.i. of 54 μg CNTLarge: Granuloma surrounded by eosinophilic necrotic hepatocytes
(long arrow), foci of necrosis (asterisks), vacuolar degeneration (short arrows), hypertrophy of Kupffer cells (head of arrows). (J) 28 days a.i. of 162 μg CNTLarge: Granuloma surrounded by
eosinophilic necrotic hepatocytes (long arrow), foci of necrosis (asterisks), vacuolar degeneration (short arrows), hypertrophy of Kupffer cells (head of arrows). (K) typical microscopic
pattern of the mouse liver — the control group. Staining HE, magniﬁcation on the ﬁgures A–J as scale in K.
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completely reversed to basal levels by day 28 post-exposure. Thus,
blood levels of HDL and LDL/VLDL cholesterol followed a time-course
similar to what has been described for a strong APR in mice subcutane-
ously injected with silver nitrate (Lindhorst et al., 1997). During APR,
SAA becomes incorporated into HDL thereby replacing ApoA-1
(Feingold and Grunfeld, 2010). Acute phase HDL is defective in reverse
cholesterol transport, resulting in reduced cholesterol efﬂux from mac-
rophages and lowered hepatic cholesterol excretion (Lindhorst et al.,
1997; Banka et al., 1995; Artl et al., 2000; Annema et al., 2010).
We found that pulmonary exposures to the two very different
MWCNTs elicit similar hepatic gene expression patterns. Whereas
Saa3 primarily drives the pulmonary APR (Bourdon et al., 2012a;
Halappanavar et al., 2011; Saber et al., 2013, 2014), both Saa1 and
Saa2were differentially expressed as part of the hepatic APR. This is in
agreement with previous observations (Uhlar and Whitehead, 1999).
Functional analyses revealed that GO biological processes and IPA func-
tions involved in cholesterol homeostasis and lipid metabolism were
perturbed following exposure to both types of MWCNTs. This was driv-
en, in part, by a uniform down-regulation of genes across the entire
HMG-CoA reductase pathway (Hmgcr, Mvk, Pmvk, Mvd, Fdps, Sqs, Sqle,
Dhcr7). Interestingly the opposite was observed in the lungs. In lungs,
CNTSmall and CNTLarge induced consistent up-regulation of several
genes involved in the HMG-CoA reductase pathway. The HMG-CoA re-
ductase pathway is activated during low-sterol conditions and plays a
central role both in the synthesis of cholesterol and in the production
of intermediates for terpenoid synthesis, actin cytoskeleton remodeling,
hormones and protein prenylation (Liao, 2002). However, the down-
regulated expression levels of Sqle and Dhcr7 in the liver indicate that
MWCNT speciﬁcally targets cholesterol synthesis. The HMG-CoA reduc-
tase pathway is regulated by a negative feedback loop; the down-
regulation is most likely due to the increased cholesterol levels in
plasma (CNTSmall and CNTLarge) and liver (CNTLarge only).
In the present study, the systemic effects of MWCNT exposure were
evaluated in femalemice. Similarly increased plasma levels of SAAwere
recently reported for male mice exposed toMWCNTs (Kim et al., 2014).
Lipoprotein proﬁles among pre-menopausal women differ from men's,
as they have lower LDL cholesterol levels while HDL cholesterol levels
are higher. Also, LDL cholesterol levels in post-menopausal women are
equal to, or higher than, those in age-matched males, and can be
lowered by hormone replacement therapy (Skafar et al., 1997). Thus, a
cardioprotective effect of female sex hormones, particularly estrogen,
has been proposed (Skafar et al., 1997; De Marinis et al., 2008). It is
therefore possible that the differences in systemic HDL levels following
MWCNT exposure observed between the study of (Kim et al., 2014) and
our study are related to the gender of the experimental animals. A study
in rats reported gender-related differences in the HMG-CoA reductase
pathway, with females having lower activity and expression of 3-
hydroxy 3-methylglutaryl coenzyme A reductase (Hmgcr), the rate-
limiting enzyme in the HMG-CoA reductase pathway, compared to
age-matched males (De Marinis et al., 2008). Similar differences were
observed when comparing non-treated males with males treated with
17-β-estradiol, indicating an estrogen-reduction of the HMG-CoA re-
ductase pathway. Thus, the present study adds to the overall weight of
evidence of systemic acute phase response in mice following MWCNT
exposure in both genders.
Studies in rodents have shown that severe inﬂammation, initiated
through intraperitoneal injection of LPS, induces the hepatic HMG-CoA
reductase pathway (Feingold et al., 1993, 1995; Memon et al., 1993).
Perturbations in the hepatic HMG-CoA reductase pathways were also
observed following pulmonary exposure to nano-CB (Bourdon et al.,
2012a). However, the directions of the observed effects were opposite.
HMG-CoA was up-regulated following nano-CB exposure, whereas, it
was down-regulated following exposures to both types of MWCNTs.
Another difference includes the down-regulation of Ldlr in the livers of
MWCNTs exposed mice in the present study, but no effects following
LPS and nano-CB exposure (Bourdon et al., 2012a; Feingold et al.,
1993, 1995). Ldlr and Hmgcr are regulated in a coordinated fashion
with parallel increases or decreases in mRNA levels in response to
stimuli (Goldstein and Brown, 1990), as observed in the present study.
Ldlr primarily facilitates the transport of VLDL, intermediate-density li-
poproteins and LDL across the membrane (Lagor and Millar, 2010),
and the hepatic down-regulation of Ldlr could in part explain the in-
creased plasma levels of LDL/VLDL. Thus, the observed dissimilarities
between our results and those of others (Bourdon et al., 2012a;
Feingold et al., 1993, 1995) indicate that MWCNT exposure may elicit
hepatic and systemic responses related to their structures, that differ
from responses seen following LPS and nano-CB exposure.
The dissimilarities observed between nano-CB relative to MWCNT
exposures may result from greater and more prolonged APR (observed
at both mRNA and protein levels) following MWCNT exposure than
those observed following nano-CB. Plasma SAA levels were at least
30-fold increased following MWCNT exposure, whereas a maximum
increase of 15.6% has previously been observed following a similar
nano-CB exposure (Bourdon et al., 2012a). The greater and prolonged
APR would lead to a higher proportion of circulating HDL-SAA. Besides
having decreased cholesterol efﬂux ability, HDL-SAA is also able to
transform peripheral macrophages into foam cells, and to promote
plaque progression in APOE−/− mice (Artl et al., 2000; Lee et al.,
2013). Thus, our results indicate that increased HDL-SAA levels may
present a signiﬁcant risk factor for CVD following MWCNT exposure.
Supplementary Fig. 4 depicts the observed pulmonary, systemic and
hepatic changes following pulmonary MWCNT exposure. In particular,
we note that down-regulation of hepatic expression of Abcg5 and
Abcg8 occurs following exposure to both types of MWCNTs (Supple-
mentary Table 1). Abcg5 and Abcg8 encode biliary transporters that fa-
cilitate cholesterol excretion into the bile (Yu et al., 2002). Biliary
excretion is a major function in reverse cholesterol transport, and
decreased expression of Abcg5 and Abcg8 has been linked to retention
of cholesterol in the liver (McGillicuddy et al., 2009). Due to the pertur-
bations observed for many steps in the reverse cholesterol transport, it
is possible that the observed increased APRmayhave a direct or indirect
effect on bile excretion of cholesterol, which, in part, could explain the
observed increase in hepatic cholesterol levels. In addition, our
toxicogenomics analysis of hepatic gene expression revealed a general
inﬂammatory response in the liver, which is known to affect bile excre-
tion (McGillicuddy et al., 2009).
Intratracheal instillation of either type of MWCNTs in mice caused
histological changes in the liver. An increased number of binucleate
hepatocytes in MWCNT treated mice were observed, indicating
hepatocytic regeneration typically seen after a toxic insult (Kostka
et al., 2000). Similar increases in binucleated hepatocytes have previ-
ously been reported following nanoparticle-exposure (Hougaard et al.,
2013; Kostka et al., 2000; Saber et al., 2012). Other indications of
systemic MWCNT-induced mild liver injury in our study include the
following: microfoci of necrosis, eosinophilic necrosis of single hepato-
cytes, and hepatocytes with pyknotic nuclei (Fig. 4 and Supplementary
Table 5), which all are frequent sequels to liver injury (Haschek et al.,
2010). MWCNT also induces hepatic inﬂammatory changes. Small foci
of inﬂammatory cells, polymorphonuclear cell foci, macrophages, and
granulomaswere observed. Although scattered inﬂammatory cell accu-
mulations are commonly observed in untreated mice (Haschek et al.,
2010), these were more frequent in the MWCNT-treated mice. In-
creased numbers and/or hypertrophy of Kupffer cells could be related
to one of their functions in the liver, production of mediators of inﬂam-
mation (Harrada et al., 1999). Hepatic focal necrosis, single cell necrosis,
inﬂammatory changes and hyperplasia or hypertrophy of Kupffer cells
have been observed in mice after intratracheal instillation of other
nanoparticles (Hougaard et al., 2013; Saber et al., 2012) and in rats ex-
posed by inhalation to nanoparticles (Sung et al., 2009; Ji et al., 2007).
The histological hepatic effects of exposure to the two MWCNTs are
similar in types of lesions induced, but CNTLarge exposure causes larger
granulomas, and the incidence of vacuolar degeneration tended to be
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higher. Vacuolar degeneration was distributed throughout the whole
area of the hepatic lobule and its location did not change with time.
Also the eosinoﬁlic necrosis of hepatocytes of a single row of hepato-
cytes surrounding the central vein was characteristic for livers from
the CNTLarge exposure groups. In general the histological changes were
not indicative of strong toxicity.
Although the gene expression patterswere highly similar after expo-
sure to either CNT, our data also indicated subtle differences in gene ex-
pression and lipid concentrations following CNTSmall or CNTLarge
exposure. Only CNTSmall exposure resulted in changes in hepatic gene
expression at day 28 and the number of differentially expressed genes
was greater than that in the CNTLarge groups. CNTSmall caused an earlier
onset in the down-regulation of the HMG-CoA reductase pathway than
CNTLarge; the expression of Ldlrwas differentially down-regulated even
at the lowest dose at days 1 and 3 following CNTSmall exposure (Table 2).
Exposure to CNTLarge, on the other hand, seemed to induce a greater he-
patic APR in accordancewith the recordedmorphological inﬂammatory
changes. However, despite these functional differences and different
physicochemical properties, the responses following CNTSmall and
CNTLarge exposures were more similar than different.
MWCNTs are HARN (high aspect ratio nanoparticles) and have, as
such, been extensively discussed in relation to asbestos toxicity. Our re-
sults show that pulmonary exposure to MWCNT induces a pulmonary-
based systemic APR resulting in changes in cholesterol homeostasis and
liver morphology. We observed a close correlation between plasma
SAA3 levels and pulmonary Saa3 mRNA levels. We have previously
demonstrated a close correlation between pulmonary Saa3 levels and
neutrophil inﬂux (Saber et al., 2013, 2014; Halappanavar et al., 2014;
Poulsen et al., 2014). The observed APR and increased cholesterol levels
link MWCNT exposure to risk of CVD. Since Teeguarden et al. (2011)
identiﬁed the same APR proteins in the lungs of mice following expo-
sure to single-walled carbon nanotubes or asbestos, this suggests that
asbestos exposure is likely to induce a similar pulmonary APR. In con-
cordance with this, prospective studies on smoking-adjusted, occupa-
tional asbestos exposure have reported an association between
exposure to asbestos and increased risk of ischaemic heart disease
(Harding et al., 2012; Sanden et al., 1993). Thus, our ﬁndings in parallel
with others suggest that MWCNT exposure increases the risk of CVD.
The present work has established a correlation between pulmonary
and systemic APR following pulmonary exposure toMWCNTs, and sug-
gests that pulmonary APR can be used to group and rank different
nanomaterials in relation to CVD inducing potential.
Conclusion
We show that pulmonary exposure to two very different MWCNTs
induced very similar systemic APR, with induced alterations in plasma
levels of APR proteins, cholesterol, LDL/VLDL and HDL, and changes in
hepatic gene expression and liver morphology. Furthermore, we found
a close correlation between plasma SAA3 levels and pulmonary Saa3
mRNA levels. Taken together, the results link pulmonary exposure to
MWCNTs with risk of CVD.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.taap.2015.01.011.
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